| Home | E-Submission | Sitemap | Contact Us |  
Principles of Transparency and Best Practice > About > Principles of Transparency and Best Practice



As an open access journal, Child Kidney Dis will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).
1. Website
1) The URL of official journal web site is http://chikd.org

2) 쁀ims & scope statement
Child Kidney Dis covers clinical and research works relevant to all aspects of pediatric nephrology including following forms of review article, original article, case report, editorial, letters to editor, and so on. The Journal aims to serve pediatricians through the prompt publication of significant advances in pediatric nephrology and to rapidly disseminate recently updated knowledge to the public. Additionally, it will initiate dynamic, international, academic discussions concerning the major topics related to pediatric nephrology

3) Readership
It is primarily for scientists and clinicians active or interested in the field of pediatric nephrology, but its readership can be expanded to other positions: researchers, clinicians, professors, medical health students, allied health professionals, and policy makers in the field of pediatrics, neonatology, nephrology, urology, pathology, endocrinology, cardiology, neurology, gastroenterology, gynecology/obstetrics, epidemiology, pharmacology, biochemistry, and molecular & cell biology.

4) Authorship criteria
An author is considered as an individual who has made substantive intellectual contributions to a published study and whose authorship continues to have important academic, social, and financial implications. The ICMJE has recommended the following criteria for authorship: 1) substantial contributions to conception and design, acquisition, analysis, and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet criteria 1, 2, and 3. These criteria are applicable to those journals that distinguish the authors from other contributors.

5) ISSN
print ISSN 1226-5292; online ISSN 2234-4209

2. Name of Journal
Childhood Kidney Diseases is the official publication of the Korean Society of Pediatric Nephrology .Its formal abbreviated title is 쏞hild Kidney Dis.

3. Peer Review Process
Child Kidney Dis reviews all received materials. All papers are evaluated by a double-blind, peer-review process. Manuscripts are sent to the two (or more) most relevant investigators, for reviews of the contents. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 2 weeks after the agreement of review by the reviewers, and the reviewers comments will then be sent to the corresponding authors. Revised manuscripts must be submitted online by the corresponding author. Failure to resubmit the revised manuscript within 2 weeks of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format or the order of the manuscript. The editor selects referees results of the review will be classified as follows:

  • Accepted: The manuscript will be forwarded to the publisher without further corrections.
  • Minor revisions: The author should address the comments from the reviewers, which will be confirmed by the reviewers.
  • Major revisions: The author should address the comments from the reviewers and make the appropriate corrections for review by the three reviewers.
  • Rejection: When one out of the two (or more) reviewers rejects the manuscript, the final decision is made by the editorial committee.
4. Ownership and Management
1) Ownership
This journal is owned by the publisher, Korean Society of Pediatric Nephrology (http://www.kspn.org)

2) Management team
Editor-in-Chief Jae Il Shin Editor-in-Chief, Yonsei University
  Hyung Eun Yim Editor-in-Chief, Korea University
Manuscript Editor Keum Hwa Lee Yonsei University
  Eun Mi Yang Chonnam University
Managing Editor Hye Sun Hyun Catholic University
Website and JATS XML File Producers Yoon-Sang Cho M2community, Korea


5. Governing Body
The governing body is the journal's editorial board (http://www.chikd.org/about/editorial.php).

6. Editorial Team and Contact Information
7. Copyright and Licensing
All published papers become the permanent property of the Child Kidney Dis. Copyrights of all published materials are owned by the Child Kidney Dis. They also follow the Creative Commons Attribution Non-Commercial License available from: http://creativecommons.org/licenses/by-nc/3.0/. For any commercial use of material from the open access version of the journal, permission must be obtained from the Child Kidney Dis. Every author should sign the authorship responsibility and copyright transfer agreement form, attesting that he/she fulfills the authorship criteria. Authors are required to identify their contributions to the work described in the manuscript. The manuscript, when published, will become the property of the journal.

8. Author fees
There is no submission fee or page charge. Article processing charge can be applied for accepted articles, according to the number of tables or figures (approximately $20~$50).

9. Process for Identification of and Dealing with Allegations of Research Misconduct
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author셲 idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the editorial board of the Child Kidney Dis. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Publication Ethics
1) Authorship and Contributorship
An author is considered as an individual who has made substantive intellectual contributions to a published study and whose authorship continues to have important academic, social, and financial implications. The ICMJE has recommended the following criteria for authorship: 1) substantial contributions to conception and design, acquisition, analysis, and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet criteria 1, 2, and 3. If any persons who do not meet the above four criteria, they may be placed as contributors in the Acknowledgments section.

2) Complaints and Appeal
The policy of Child Kidney Dis is principally intended to protect the authors, reviewers, editors, and the publisher of the journal. The process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from: https://publicationethics.org/appeals.

3) Conflicts of Interest
Conflict of interest exists when an author (or the author셲 institution), reviewer, or editor has financial or personal relationships that inappropriately influence his/her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). All authors should disclose their conflicts of interest, i.e., 1) financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony), 2) personal relationship, 3) academic competition, and 4) intellectual passion. These conflicts of interest must be included as a footnote on the title page or in the acknowledgement section. Each author should certify the disclosure of any conflict of interest with his/her signature. If no conflict exists, please state that 쁔he Author(s) declare(s) that there is no conflict of interest.

4) Data Sharing and Reproducibility
A. Open data policy
Child Kidney Dis does not require mandate data sharing. In the interest of transparency and in support of FAIR data principles (https://www.go-fair.org/fair-principles/), however, authors would be asked to provide the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, in order that this statement can be published in their paper. Shared data should be cited.

B. Clinical data sharing policy
This journal follows the data sharing policy described in 쏡ata Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors (https://doi.org/10.3346/jkms.2017.32.7.1051). As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of interventional clinical trials must contain a data sharing statement as described below. Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trial's registration. The ICMJE's policy regarding trial registration is explained at https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit data sharing plan. Based on the degree of sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.

5) Ethical Oversight (Research Ethics, Informed Consent, IRB)
Child Kidney Dis follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr). Our publication ethics are displayed on the Ethical Policy tab of journal homepage (http://www.chikd.org/authors/guide.php).

6) Intellectual Property
All published papers, when published, will become the property of the journal. Copyrights of all published materials are owned by the Korean Society of Pediatric Nephrology.

7) Post-publication Discussions
The postpublication discussion is available through letter to the editor. If any readers have a concern on any articles published, they can submit letter to the editor on the articles. If there founds any errors or mistakes in the article, it can be corrected through errata, corrigenda, or retraction.

11. Publishing Schedule
Child Kidney Dis is published 2 times (April 30, October 31) a year. The e-pub versions of all articles have been promptly seen after the acceptance in the journal homepage.

12. Access
Child Kidney Dis is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

13. Archiving
Full text of Child Kidney Dis is accessible without barrier from Korea Citation Index (https://www.kci.go.kr/kciportal/main.kci) or National Library of Korea (http://www.nl.go.kr/english/index.jsp).

14. Revenue Sources
Revenue sources of this journal are from the support of publisher (the Korean Society of Pediatric Nephrology), Korea Government셲 support, and advertising rates.

15. Advertising
We accept advertising and sponsorship for its printed journal according to the following principles:
- Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
- We reserve the right to decline or cancel any advertisement at any time.
- Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

16. Direct Marketing
Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

Author's Index
Author's Index
Manuscript Submission
To submit a manuscript, please visit the Child Kidney Dis e-submission management system at esubmit, read the Instructions for Authors, and log into the Child Kidney Dis e-submission system. For assistance with manuscript submission, please contact: ckdeditor@kspn.org.
Free archive
Anyone may access any past or current articles without logging in.
Editorial Office
124 Bukbyunjeung-ro, Kimpo, Jesewoong 2-103, Gyeonggi-do 10098, Republic of Korea
TEL : +82-31-987-5963   FAX : +82-31-987-5967   E-mail : chikd.editor@gmail.com or ckdeditor@kspn.org

Copyright© Korean Society of Pediatric Nephrology. All rights reserved.                powerd by m2community
About |  Browse Articles |  Current Issue |  For Authors and Reviewers